Brain cancer stem cells display preferential sensitivity to Akt inhibition. - Wikidata - awgldk - TriplyDB

Brain cancer stem cells display preferential sensitivity to Akt inhibition.

Brain cancer stem cells display preferential sensitivity to Akt inhibition.

http://www.wikidata.org/entity/Q37335643

about

MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma Radioresistance of Brain Tumors Multiple cues on the physiochemical, mesenchymal, and intracellular trafficking interactions with nanocarriers to maximize tumor target efficiency Brain tumor stem cells: Molecular characteristics and their impact on therapy GPCRs in stem cell function Targeting glioma stem cells: a novel framework for brain tumors Oct4 interaction with Hmgb2 regulates Akt signaling and pluripotency Response of breast cancer cells and cancer stem cells to metformin and hyperthermia alone or combined Improving the radiosensitivity of radioresistant and hypoxic glioblastoma.Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia.Targeting A20 decreases glioma stem cell survival and tumor growth.MiR-92b inhibitor promoted glioma cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathway The evolving landscape of glioblastoma stem cells.Drosophila as a model for context-dependent tumorigenesis.Hypoxia inducible factors in cancer stem cells.Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression.The p38 signaling pathway mediates quiescence of glioma stem cells by regulating epidermal growth factor receptor trafficking The increasing complexity of the cancer stem cell paradigm Integrin alpha 6 regulates glioblastoma stem cells.Potential therapeutic implications of cancer stem cells in glioblastoma CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway.The anti-hypertensive drug prazosin inhibits glioblastoma growth via the PKCδ-dependent inhibition of the AKT pathway.Targeting pediatric cancer stem cells with oncolytic virotherapy Glioma-propagating cells as an in vitro screening platform: PLK1 as a case study.Chloroquine or chloroquine-PI3K/Akt pathway inhibitor combinations strongly promote γ-irradiation-induced cell death in primary stem-like glioma cells Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance.Lyn facilitates glioblastoma cell survival under conditions of nutrient deprivation by promoting autophagy.A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells.Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells.Human papillomavirus 16 infection predicts poor outcome in patients with esophageal squamous cell carcinoma.Prevention against diffuse spinal cord astrocytoma: can the Notch pathway be a novel treatment target?Hyperthermia Sensitizes Glioma Stem-like Cells to Radiation by Inhibiting AKT Signaling.Radiosensitization of Primary Human Glioblastoma Stem-like Cells with Low-Dose AKT Inhibition.Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth.Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner.CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays Glioma revisited: from neurogenesis and cancer stem cells to the epigenetic regulation of the niche Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies.

P2860

Q21245708-E7652E20-A9AA-4FD8-B8DC-EA666B8D808B Q26752579-B331447A-C634-4845-9F86-C69DEA1F6422 Q26827999-C9C4C850-3A94-46CD-B266-615AB5E443DA Q27003138-B63E7921-5B2F-442C-B178-B8507F30843D Q27003270-BE0CFA50-43DB-4A4C-9A3C-1466472ABC81 Q27026818-99A0E312-98EA-40F7-85F6-947CF0B4BD1A Q28511152-8C3C76A0-31BC-4D4F-A682-703BA17B9975 Q28539523-18EE0459-20B9-489A-AC25-C4D6ED66E8E5 Q30452219-7BED17AE-731B-45F2-8DB1-58D595F72854 Q33493174-FF4F0DC9-9090-4EA5-B50D-10B60F97AF7F Q33534629-B950DCB5-EF3B-4CF8-967B-CCC2DA31A1F5 Q33641219-3908338A-723A-4313-8671-3FA01EFC2B37 Q33652614-B3467F87-748B-4EE1-82A3-2BFEDF82BE69 Q33666519-4031654B-EE04-4CC9-A492-904CB899F4D6 Q33708114-E58DA187-F06A-44BD-A465-299015DA974A Q33764821-3B451DDF-D7FB-4004-9D95-CB8137EA6F29 Q33779353-629E8C17-AC76-4528-A61A-034498D236FF Q33779457-C71EF395-F58F-4622-AAB9-C96F5DDFBE16 Q33862363-D9B3C1BC-2060-4837-BA9E-B5A5893B0616 Q33908472-5BADD288-20A5-4EC9-853F-43A6FA9581EF Q33965491-02E219C5-2EB6-42C1-948D-3A797A807887 Q34018947-6A4013BB-0849-47CA-A06F-DA61E831F70C Q34046737-917A46C2-FA69-4D9D-A002-FB51B9641345 Q34262327-0ECA76D3-B569-4B0B-B176-34C8CD678FC5 Q34395146-7485883E-71D6-4626-973B-CACFC816E6FD Q34455213-437DE64E-EBAA-4793-BCF2-17C64F403794 Q34662363-005745AD-BB69-434D-8F3C-67070C72127A Q34926222-6EF02C29-AA89-4D63-B905-DC2B095A9AC9 Q35023915-A61A627C-677A-4F23-A6E7-F753E9B97C17 Q35055652-BEF72418-7250-4A70-A018-3A9D51B7DA10 Q35168715-10D97B98-68D2-4187-9326-E0D8C10C9439 Q35356912-FFC4F287-676F-47A8-AA79-992B5838E65A Q35463653-9877EC83-5BC3-447C-BE1F-1C2437C6AB67 Q35587475-0ABE614A-9217-4ACC-A4E0-05B51F2AD7CD Q35826030-192ADD92-C426-4EA8-AE76-9E3249F7E51D Q35884622-D59181E8-C849-4A1F-9C67-500265EF9B92 Q35957393-B3BAB024-2B57-4D6D-BA48-AD253094F34B Q36209001-EC377977-1886-4E5D-97E6-13DF81107AF5 Q36225175-A9F5F185-AB66-4709-9779-282DCB65AFA4 Q36280796-BC783B88-6350-4777-A862-C33668645902

P2860

Brain cancer stem cells display preferential sensitivity to Akt inhibition.

http://www.wikidata.org/entity/Q37335643

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Brain cancer stem cells display preferential sensitivity to Akt inhibition.

@en

Brain cancer stem cells display preferential sensitivity to Akt inhibition.

@nl

type

label

Brain cancer stem cells display preferential sensitivity to Akt inhibition.

@en

Brain cancer stem cells display preferential sensitivity to Akt inhibition.

@nl

prefLabel

Brain cancer stem cells display preferential sensitivity to Akt inhibition.

@en

Brain cancer stem cells display preferential sensitivity to Akt inhibition.

@nl

P1433

Q37335643-320FB6D3-F4E8-4CDD-8D3A-1C807BCBCA62

P1476

Q37335643-DB01C241-9C0E-492A-8EB0-951DC2D78771

P2093

Q37335643-50C911A5-9646-4A4F-A5F5-36FCD068CE76

Q37335643-578A7883-9BD5-4BFB-9413-1DC6BE56EA80

Q37335643-7AB6F616-4E5B-4D7D-ADF7-8B2731056027

Q37335643-8DC17EE8-56FC-41FC-9B81-B17BBD8C5913

P2860

Q37335643-05B2F592-C1C3-4F7D-9649-0A27E1B9C782

Q37335643-125C104D-7163-46B6-93EF-F68FAE3122FA

Q37335643-137411EF-1117-445C-8B4E-8F4680204CD7

Q37335643-1B7D3537-A9FA-4839-9898-AD3174CBEA54

Q37335643-1F95C226-0112-426C-A44C-9B7A563673FE

Q37335643-24B33134-95BE-4058-B9BB-AB037D93089C

Q37335643-26CED568-D240-42C5-B934-EF69869AD11F

Q37335643-297D346D-B5C2-4864-BDDB-5981B3ED923E

Q37335643-387EF702-D14E-47D7-AF38-600036AC7C4B

Q37335643-42989FED-4916-4A6F-9DA1-481DBBAA5F32

P304

Q37335643-9E079218-CB47-473A-A3CA-E7919C39DB46

P31

Q37335643-3EACE7A5-ACD1-4D15-94EC-FDE145250C7D

P356

Q37335643-24CA3177-A677-472D-A2B6-35AEDE99FA3A

P433

Q37335643-0C7DE448-0DB2-4B43-80ED-C1E39090D9B8

P478

Q37335643-4FC8A34D-E26D-42D9-8E17-364528DA043B

P50

Q37335643-83879BB2-EE89-4255-9E1C-C44BC13244BC

Q37335643-9882CD5B-27C7-4234-990E-192ECEB7FF34

P577

Q37335643-E7931AB6-0446-4041-AEB3-209BE59EBAE9

P5875

Q37335643-8AB40D79-3A62-4DF6-B1E1-D246A170E8A2

P698

Q37335643-A788E7AC-7145-4AD7-B757-34D3C3859312

P932

Q37335643-ED0A164B-4ABD-4A4E-BC14-C47FB6D6119E

P356

STEMCELLS.2007-1073

P1433

P1476

Brain cancer stem cells display preferential sensitivity to Akt inhibition.

@en

P2093

Christine E Eyler

http://www.w3.org/2001/XMLSchema#string

Jeremy N Rich

http://www.w3.org/2001/XMLSchema#string

Katherine M LaFiura

http://www.w3.org/2001/XMLSchema#string

Wen-Chi Foo

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

Cancerous stem cells can arise from pediatric brain tumors

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Identification of human brain tumour initiating cells

Identification of a cancer stem cell in human brain tumors

CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells

Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

P304

3027-3036

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/STEMCELLS.2007-1073

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Anita B Hjelmeland

Roger E McLendon

P577

2008-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23265395

http://www.w3.org/2001/XMLSchema#string

P698

18802038

http://www.w3.org/2001/XMLSchema#string

P932

2739007

http://www.w3.org/2001/XMLSchema#string